NCT07198477Not yet recruiting
Sleep Disturbances and Their Association With Serum Magnesium Level in Patients With Major Depressive Disorder
Source: ClinicalTrials.gov · Last updated 30 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This cross-sectional study investigates the relationship between serum magnesium levels and the presence of sleep disturbances among patients with major depressive disorder (MDD).
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 90 (estimated)
- First submitted
- 29 Sept 2025
- Start date
- 30 Aug 2026
- Primary completion date
- 30 Oct 2027
- Lead sponsor
- Assiut University
- Diseases
- Depression
- NCT number
- NCT07198477
What you commit to
- Study type: Observational
- Planned participants: 90
- From 30 Aug 2026 to the primary completion date, 30 Oct 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Lab values
- hronic renal failure or metabolic disorders affecting magnesium balance
- Current use of medications known to significantly interfere with serum magnesium (e.g., long-term diuretics, proton pump inhibitors) unless stable and documented
- Presence of other comorbid psychiatric disorders
- Cognitive impairment or language difficulties preventing questionnaire completion
Who the study is looking for
- Confirmed diagnosis of major depressive disorder
- age 18 years and older
- Ability to complete questionnaires (BDI-II and PSQI; validated Arabic versions)
- Willing to participate and provide informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.